NDUFC2

NADH:ubiquinone oxidoreductase subunit C2

Details

HGNC: HGNC:7706
GeneCards: NDUFC2
NCBI: 4718
Ensembl: ENSG00000151366
UniProt: O95298
OMIM: 603845
UCSC: uc009yuw.4
VEGA: OTTHUMG00000166614
ENA: AF087659
Alias Symbols: B14.5b, HLC-1
Previous Symbols: None
Alias Names: "human lung cancer oncogene 1", "complex I subunit B14.5b"
Previous Names: "NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2 (14.5kD, B14.5b)", "NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa"

Associated Studies

Transcriptional reprogramming primes CD8+ T cells toward exhaustion in Myalgic encephalomyelitis/chronic fatigue syndrome

2024 | Iu et al

Phenotype: ME/CFS, ME/CFS - CCC criteria, ME/CFS - IOM (Institute of Medicine) 2015 criteria, Post-exertional malaise (PEM)
Immunometabolic changes and potential biomarkers in CFS peripheral immune cells revealed by single-cell RNA sequencing

2024 | Sun et al

Phenotype: ME/CFS, ME/CFS - CCC criteria, ME/CFS - Fukuda criteria, ME/CFS - IOM (Institute of Medicine) 2015 criteria, Post-exertional malaise (PEM)
A pilot study on the immune cell proteome of long COVID patients shows changes to physiological pathways similar to those in myalgic encephalomyelitis/chronic fatigue syndrome

2023 | Peppercorn et al

Phenotype: Long COVID, ME/CFS, ME/CFS - CCC criteria, ME/CFS - ICC Criteria, Post-exertional malaise (PEM)